{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:39:59Z","timestamp":1794335999073,"version":"4.9.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01ES021447"],"award-info":[{"award-number":["R01ES021447"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01ES030101"],"award-info":[{"award-number":["R01ES030101"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01ES031065"],"award-info":[{"award-number":["R01ES031065"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD034568"],"award-info":[{"award-number":["R01HD034568"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32ES007069"],"award-info":[{"award-number":["T32ES007069"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UH3OD023286"],"award-info":[{"award-number":["UH3OD023286"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011866","name":"University of Colorado Denver Colorado Clinical and Translational Sciences Institute","doi-asserted-by":"publisher","award":["KL2-TR002534"],"award-info":[{"award-number":["KL2-TR002534"]}],"id":[{"id":"10.13039\/100011866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012684","name":"Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012684","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environment International"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.envint.2022.107335","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T11:13:40Z","timestamp":1654514020000},"page":"107335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Early-pregnancy plasma per- and polyfluoroalkyl substance (PFAS) concentrations and hypertensive disorders of pregnancy in the Project Viva cohort"],"prefix":"10.1016","volume":"165","author":[{"given":"Emma V.","family":"Preston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-France","family":"Hivert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby F.","family":"Fleisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia M.","family":"Calafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon K.","family":"Sagiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Perng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl L.","family":"Rifas-Shiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge E.","family":"Chavarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Oken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami R.","family":"Zota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamarra","family":"James-Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.envint.2022.107335_b0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mob.2000.107928","article-title":"Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy","volume":"183","author":"Program, National High Blood Pressure Education","year":"2000","journal-title":"Am. J. Obstetrics Gynecol."},{"key":"10.1016\/j.envint.2022.107335_b0010","unstructured":"Centers for Disease Control and Prevention (CDC), 2019. Data on selected pregnancy complications in the United States."},{"key":"10.1016\/j.envint.2022.107335_b0015","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222","volume":"135","author":"ACOG","year":"2020","journal-title":"Obst. Gynecol."},{"key":"10.1016\/j.envint.2022.107335_b0020","unstructured":"ATSDR, 2021. A.f.T.S.a.D.R. Toxicological profile for Perfluoroalkyls. Atlanta, GA."},{"key":"10.1016\/j.envint.2022.107335_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2021.111183","article-title":"Using quantitative modeling tools to assess pharmacokinetic bias in epidemiological studies showing associations between biomarkers and health outcomes at low exposures","volume":"197","author":"Andersen","year":"2021","journal-title":"Environ. Res."},{"key":"10.1016\/j.envint.2022.107335_b0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jn\/nxz197","article-title":"Sodium Intake during Pregnancy, but Not Other Diet Recommendations Aimed at Preventing Cardiovascular Disease, Is Positively Related to Risk of Hypertensive Disorders of Pregnancy","volume":"150","author":"Arvizu","year":"2020","journal-title":"J. Nutr."},{"key":"10.1016\/j.envint.2022.107335_b0035","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/ajcn\/nqaa214","article-title":"Prepregnancy adherence to dietary recommendations for the prevention of cardiovascular disease in relation to risk of hypertensive disorders of pregnancy","volume":"112","author":"Arvizu","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.envint.2022.107335_b0040","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/bmj.2.6192.693","article-title":"Perinatal mortality by birth order within cohorts based on sibship size","volume":"2","author":"Bakketeig","year":"1979","journal-title":"Br. Med. J."},{"key":"10.1016\/j.envint.2022.107335_b0045","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1289\/ehp.0901252","article-title":"Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia","volume":"118","author":"Bartell","year":"2010","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envint.2022.107335_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106442","article-title":"Exposure to perfluoroalkyl substances and blood pressure in pregnancy among 1436 women from the Odense Child Cohort","volume":"151","author":"Birukov","year":"2021","journal-title":"Environ. Int."},{"key":"10.1016\/j.envint.2022.107335_b0055","doi-asserted-by":"crossref","first-page":"27006","DOI":"10.1289\/EHP6233","article-title":"Evaluation of Maternal, Embryo, and Placental Effects in CD-1 Mice following Gestational Exposure to Perfluorooctanoic Acid (PFOA) or Hexafluoropropylene Oxide Dimer Acid (HFPO-DA or GenX)","volume":"128","author":"Blake","year":"2020","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envint.2022.107335_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152565","article-title":"Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: A review including the placenta as a target tissue and possible driver of peri- and postnatal effects","volume":"443","author":"Blake","year":"2020","journal-title":"Toxicology"},{"key":"10.1016\/j.envint.2022.107335_b0065","doi-asserted-by":"crossref","unstructured":"Bobb, J.F., 2017. bkmr: Bayesian Kernel Machine Regression. R package version 0.2.0.","DOI":"10.32614\/CRAN.package.bkmr"},{"key":"10.1016\/j.envint.2022.107335_b0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12940-018-0413-y","article-title":"Statistical software for analyzing the health effects of multiple concurrent exposures via Bayesian kernel machine regression","volume":"17","author":"Bobb","year":"2018","journal-title":"Environ. Health"},{"key":"10.1016\/j.envint.2022.107335_b0075","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/biostatistics\/kxu058","article-title":"Bayesian kernel machine regression for estimating the health effects of multi-pollutant mixtures","volume":"16","author":"Bobb","year":"2015","journal-title":"Biostatistics (Oxford, England)"},{"key":"10.1016\/j.envint.2022.107335_b0080","doi-asserted-by":"crossref","DOI":"10.1289\/EHP9091","article-title":"Maternal Levels of Perfluoroalkyl Substances (PFAS) during Early Pregnancy in Relation to Preeclampsia Subtypes and Biomarkers of Preeclampsia Risk","volume":"129","author":"Bommarito","year":"2021","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envint.2022.107335_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.105789","article-title":"Association of perfluoroalkyl substances with gestational hypertension and preeclampsia in the MIREC study","volume":"141","author":"Borghese","year":"2020","journal-title":"Environ. Int."},{"key":"10.1016\/j.envint.2022.107335_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2019.105048","article-title":"Legacy and alternative per- and polyfluoroalkyl substances in the U.S. general population: Paired serum-urine data from the 2013-2014 National Health and Nutrition Examination Survey","volume":"131","author":"Calafat","year":"2019","journal-title":"Environ. Int."},{"key":"10.1016\/j.envint.2022.107335_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2020.128899","article-title":"Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and birth outcomes: A longitudinal cohort with repeated measurements","volume":"267","author":"Chen","year":"2021","journal-title":"Chemosphere"},{"key":"10.1016\/j.envint.2022.107335_b0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fphar.2014.00065","article-title":"Physiologic and pharmacokinetic changes in pregnancy","volume":"5","author":"Costantine","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.envint.2022.107335_b0105","first-page":"56","article-title":"Hypertensive Disorders of Pregnancy and Cardiovascular Diseases: Current Knowledge and Future Directions","volume":"20","author":"Coutinho","year":"2018","journal-title":"Curr. Treat Opt. Cardiovasc. Med."},{"key":"10.1016\/j.envint.2022.107335_b0110","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/j.ackd.2020.05.006","article-title":"Hypertensive Disorders of Pregnancy","volume":"27","author":"Dines","year":"2020","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.envint.2022.107335_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.105784","article-title":"Pharmacokinetic bias analysis of an association between clinical thyroid disease and two perfluoroalkyl substances","volume":"141","author":"Dzierlenga","year":"2020","journal-title":"Environ. Int."},{"key":"10.1016\/j.envint.2022.107335_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2021.111113","article-title":"Considering environmental exposures to per- and polyfluoroalkyl substances (PFAS) as risk factors for hypertensive disorders of pregnancy","volume":"197","author":"Erinc","year":"2021","journal-title":"Environ. Res."},{"key":"10.1016\/j.envint.2022.107335_b0125","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/etc.4890","article-title":"Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research","volume":"40","author":"Fenton","year":"2021","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.envint.2022.107335_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization Paths for Generalized Linear Models via Coordinate Descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.envint.2022.107335_b0135","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/s41430-017-0068-8","article-title":"Associations of the dietary approaches to stop hypertension (DASH) diet with pregnancy complications in Project Viva","volume":"72","author":"Fulay","year":"2018","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.envint.2022.107335_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2021.111632","article-title":"Per- and polyfluoroalkyl substances exposure during pregnancy and adverse pregnancy and birth outcomes: A systematic review and meta-analysis","volume":"201","author":"Gao","year":"2021","journal-title":"Environ. Res."},{"key":"10.1016\/j.envint.2022.107335_b0145","doi-asserted-by":"crossref","DOI":"10.1002\/etc.5182","article-title":"Environmental Sources, Chemistry, Fate and Transport of Per- and Polyfluoroalkyl Substances: State of the Science, Key Knowledge Gaps, and Recommendations Presented at the August 2019 SETAC Focus Topic Meeting","author":"Guelfo","year":"2021","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.envint.2022.107335_b0150","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/CS20150702","article-title":"The role of inflammation in the pathology of preeclampsia","volume":"130","author":"Harmon","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.envint.2022.107335_b0155","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.placenta.2009.12.009","article-title":"Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia","volume":"31","author":"Holdsworth-Carson","year":"2010","journal-title":"Placenta"},{"key":"10.1016\/j.envint.2022.107335_b0160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12940-018-0445-3","article-title":"Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and the risk of hypertensive disorders of pregnancy","volume":"18","author":"Huang","year":"2019","journal-title":"Environ. Health"},{"key":"10.1016\/j.envint.2022.107335_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.105656","article-title":"Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort study","volume":"138","author":"Huo","year":"2020","journal-title":"Environ. Int."},{"key":"10.1016\/j.envint.2022.107335_b0170","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bpobgyn.2011.01.006","article-title":"Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy","volume":"25","author":"Hutcheon","year":"2011","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.envint.2022.107335_b0175","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.chroma.2010.10.051","article-title":"Improved selectivity for the analysis of maternal serum and cord serum for polyfluoroalkyl chemicals","volume":"1218","author":"Kato","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.envint.2022.107335_b0180","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1021\/es1043613","article-title":"Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999\u20132008","volume":"45","author":"Kato","year":"2011","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.envint.2022.107335_b0185","doi-asserted-by":"crossref","first-page":"47004","DOI":"10.1289\/EHP5838","article-title":"A Quantile-Based g-Computation Approach to Addressing the Effects of Exposure Mixtures","volume":"128","author":"Keil","year":"2020","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envint.2022.107335_b0190","first-page":"77","article-title":"Hypertensive Disorders of Pregnancy","volume":"39","author":"Khedagi","year":"2021","journal-title":"Cardiol. Clin."},{"key":"10.1016\/j.envint.2022.107335_b0195","unstructured":"Kiel, A., 2021. qgcomp: Qunatile G-Computation. R packaage version 2.8.0."},{"key":"10.1016\/j.envint.2022.107335_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106789","article-title":"Temporal trends of concentrations of per- and polyfluoroalkyl substances among adults with overweight and obesity in the United States: Results from the Diabetes Prevention Program and NHANES","volume":"157","author":"Lin","year":"2021","journal-title":"Environ. Int."},{"key":"10.1016\/j.envint.2022.107335_b0205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/15287394.2012.722523","article-title":"Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages","volume":"76","author":"Loccisano","year":"2013","journal-title":"J .Toxicol. Environ. Health A"},{"key":"10.1016\/j.envint.2022.107335_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.706352","article-title":"Exposure to Perfluoroalkyl Chemicals and Cardiovascular Disease: Experimental and Epidemiological Evidence","volume":"12","author":"Meneguzzi","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.envint.2022.107335_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106584","article-title":"Interference of C6O4 on platelet aggregation pathways: Cues on the new-generation of perfluoro-alkyl substance","volume":"154","author":"Minuz","year":"2021","journal-title":"Environ. Int."},{"key":"10.1016\/j.envint.2022.107335_b0220","doi-asserted-by":"crossref","first-page":"e3415","DOI":"10.1210\/clinem\/dgaa431","article-title":"Pregnancy Per- and Polyfluoroalkyl Substance Concentrations and Postpartum Health in Project Viva: A Prospective Cohort","volume":"105","author":"Mitro","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.envint.2022.107335_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101897","article-title":"Maternal glomerular filtration rate in pregnancy and fetal size","volume":"9","author":"Morken","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.envint.2022.107335_b0230","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/ije\/dyu008","article-title":"Cohort profile: project viva","volume":"44","author":"Oken","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.envint.2022.107335_b0235","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.annepidem.2007.03.003","article-title":"Diet during pregnancy and risk of preeclampsia or gestational hypertension","volume":"17","author":"Oken","year":"2007","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.envint.2022.107335_b0240","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1289\/ehp.10009","article-title":"Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers","volume":"115","author":"Olsen","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envint.2022.107335_b0245","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/aogs.13534","article-title":"Risk of having one lifetime pregnancy and modification by outcome of pregnancy and perinatal loss","volume":"98","author":"Pirnat","year":"2019","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.envint.2022.107335_b0250","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/15287391003689317","article-title":"Perfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: role in endothelial permeability","volume":"73","author":"Qian","year":"2010","journal-title":"J. Toxicol. Environ. Health A"},{"key":"10.1016\/j.envint.2022.107335_b0255","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: Pathophysiology, Challenges, and Perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.envint.2022.107335_b0260","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/OGX.0b013e3182331028","article-title":"A critical review of early-onset and late-onset preeclampsia","volume":"66","author":"Raymond","year":"2011","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.envint.2022.107335_b0265","doi-asserted-by":"crossref","DOI":"10.3390\/toxics8020043","article-title":"Per- and Polyfluoroalkyl Substances in Early Pregnancy and Risk for Preeclampsia: A Case-Control Study in Southern Sweden","volume":"8","author":"Rylander","year":"2020","journal-title":"Toxics"},{"key":"10.1016\/j.envint.2022.107335_b0270","doi-asserted-by":"crossref","first-page":"11849","DOI":"10.1021\/acs.est.5b02489","article-title":"Sociodemographic and Perinatal Predictors of Early Pregnancy Per- and Polyfluoroalkyl Substance (PFAS) Concentrations","volume":"49","author":"Sagiv","year":"2015","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.envint.2022.107335_b0275","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/aje\/kwt314","article-title":"Invited commentary: interpreting associations between exposure biomarkers and pregnancy outcome","volume":"179","author":"Savitz","year":"2014","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.envint.2022.107335_b0280","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/EDE.0b013e31824cb93b","article-title":"Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community","volume":"23","author":"Savitz","year":"2012","journal-title":"Epidemiology (Cambridge, Mass)"},{"key":"10.1016\/j.envint.2022.107335_b0285","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.envint.2022.107335_b0290","first-page":"175","article-title":"Selective fertility - the examples of perinatal death and preeclampsia","volume":"17","author":"Skjaerven","year":"2007","journal-title":"Norsk Epidemiologi"},{"key":"10.1016\/j.envint.2022.107335_b0295","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7677","article-title":"Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study","volume":"345","author":"Skjaerven","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.envint.2022.107335_b0300","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/oxfordjournals.aje.a115088","article-title":"Selective fertility and the distortion of perinatal mortality","volume":"128","author":"Skjaerven","year":"1988","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.envint.2022.107335_b0305","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/aje\/kwt432","article-title":"Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study","volume":"179","author":"Starling","year":"2014","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.envint.2022.107335_b0310","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/aje\/kwp212","article-title":"Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome","volume":"170","author":"Stein","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.envint.2022.107335_b0315","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/M17-2740","article-title":"Hypertensive Disorders of Pregnancy and Maternal Cardiovascular Disease Risk Factor Development: An Observational Cohort Study","volume":"169","author":"Stuart","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.envint.2022.107335_b0320","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41370-018-0094-1","article-title":"A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects","volume":"29","author":"Sunderland","year":"2019","journal-title":"J. Eposure Sci. Environ. Epidemiol."},{"key":"10.1016\/j.envint.2022.107335_b0325","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s40572-020-00279-0","article-title":"Perfluoroalkyl Substances (PFAS) and Their Effects on the Placenta, Pregnancy, and Child Development: a Potential Mechanistic Role for Placental Peroxisome Proliferator-Activated Receptors (PPARs)","volume":"7","author":"Szilagyi","year":"2020","journal-title":"Curr. Environ. Health. Rep."},{"key":"10.1016\/j.envint.2022.107335_b0330","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/toxsci\/kfaa043","article-title":"Per- and Polyfluoroalkyl Substances Differentially Inhibit Placental Trophoblast Migration and Invasion In Vitro","volume":"175","author":"Szilagyi","year":"2020","journal-title":"Toxicol. Sci.: Offic. J. Soc. Toxicol."},{"key":"10.1016\/j.envint.2022.107335_b0335","unstructured":"Team, R.C. R, 2013. A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing."},{"key":"10.1016\/j.envint.2022.107335_b0340","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.reprotox.2019.04.004","article-title":"Heightened susceptibility: A review of how pregnancy and chemical exposures influence maternal health","volume":"92","author":"Varshavsky","year":"2020","journal-title":"Reprod. Toxicol. (Elmsford, NY)"},{"key":"10.1016\/j.envint.2022.107335_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106747","article-title":"Exposure to endocrine disrupting chemicals (EDCs) and cardiometabolic indices during pregnancy: The HOME Study","volume":"156","author":"Vuong","year":"2021","journal-title":"Environ. Int."},{"key":"10.1016\/j.envint.2022.107335_b0350","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.envint.2018.01.027","article-title":"Perfluoroalkyl substances, glucose homeostasis, and gestational diabetes mellitus in Chinese pregnant women: A repeat measurement-based prospective study","volume":"114","author":"Wang","year":"2018","journal-title":"Environ. Int."},{"key":"10.1016\/j.envint.2022.107335_b0355","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jacc.2021.01.018","article-title":"Hypertensive Disorders of Pregnancy and Subsequent Risk of Premature Mortality","volume":"77","author":"Wang","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.envint.2022.107335_b0360","doi-asserted-by":"crossref","first-page":"9179","DOI":"10.1038\/s41598-019-45483-7","article-title":"Early pregnancy serum levels of perfluoroalkyl substances and risk of preeclampsia in Swedish women","volume":"9","author":"Wikstr\u00f6m","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envint.2022.107335_b0365","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/toxsci\/kfn166","article-title":"Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths","volume":"106","author":"Wolf","year":"2008","journal-title":"Toxicol. Sci.: Offic. J. Soc. Toxicol."},{"key":"10.1016\/j.envint.2022.107335_b0370","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1159\/000508036","article-title":"Hypertensive Disorders of Pregnancy and Risk of Cardiovascular Disease-Related Morbidity and Mortality: A Systematic Review and Meta-Analysis","volume":"145","author":"Wu","year":"2020","journal-title":"Cardiology"},{"key":"10.1016\/j.envint.2022.107335_b0375","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.envint.2018.02.044","article-title":"Association between persistent endocrine-disrupting chemicals (PBDEs, OH-PBDEs, PCBs, and PFASs) and biomarkers of inflammation and cellular aging during pregnancy and postpartum","volume":"115","author":"Zota","year":"2018","journal-title":"Environ. Int."}],"container-title":["Environment International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0160412022002628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0160412022002628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T12:25:35Z","timestamp":1758975935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0160412022002628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":75,"alternative-id":["S0160412022002628"],"URL":"https:\/\/doi.org\/10.1016\/j.envint.2022.107335","relation":{},"ISSN":["0160-4120"],"issn-type":[{"value":"0160-4120","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early-pregnancy plasma per- and polyfluoroalkyl substance (PFAS) concentrations and hypertensive disorders of pregnancy in the Project Viva cohort","name":"articletitle","label":"Article Title"},{"value":"Environment International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.envint.2022.107335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107335"}}